期刊文献+

多发性骨髓瘤免疫表型特征及其临床意义 被引量:5

Immunophenotype and its clinical significant of multiple myeloma
下载PDF
导出
摘要 目的探讨流式细胞术检测多发性骨髓瘤(MM)的免疫表型特征及其临床意义。方法应用多参数流式细胞术(MP-FCM),采用CD138/CD45/SSC设门,检测40例MM患者和20例正常献髓者骨髓细胞免疫表型。结果 MM患者抗原异常表达率由高到低分别为CD45^(dim+/-)(95%)、CD81^(dim+/-)(80%)、CD56^+(70%)、CD27^(dim+/-)(50%)、CD200^(++)(48%)、CD33^+(40%)、CD28^(++)(35%)、CD117^+(18%)、CD19^+(5%)和CD20^+(3%)。CD56+、CD200^(dim+)、CD28^(dim+)在正常浆细胞的表达率分别为10%、10%和5%。结论应用MP-FCM检测MM细胞免疫表型,可准确地鉴别良恶性浆细胞,有助于MM的诊断、预后判断及靶向治疗。 Objective To explore the immunophenotype and its clinical significant of Multiple Myeloma( MM). Methods The immunophenotype of 40 patients with MM and 20 normal volunteers were detected by multiparameter flow cytometry( MP-FCM). Results The abnormality expression of antigens sequence of patients with MM was CD45 dim+/-( 95%),CD81 dim+/-( 80%),CD56+( 70%),CD27 dim+/-( 50%),CD200+ +( 48%),CD33+( 40%),CD28+ +( 35%),CD117+( 18%),CD19+( 5%),CD20+( 3%) in order. However the positive rations of CD56+,CD200dim +and CD28dim +were 10%,10% and 5%,respectively. Conclusion MP-FCM inspections can accurately discriminate the benign and malignant plasma cell,and provide evidence for prognosis evaluation and targeted therapy.
出处 《中国临床保健杂志》 CAS 2016年第3期228-231,337,共5页 Chinese Journal of Clinical Healthcare
基金 国家自然科学基金面上项目(81472018) 安徽省自然科学基金面上项目(1408085MH145)
关键词 多发性骨髓瘤 免疫表型分型 浆细胞 流式细胞术 Multiple myeloma Immunophenotyping Plasma Cells Flow cytometry
  • 相关文献

参考文献16

  • 1B. Paiva,N-C Gutierrez,X. Chen.Clinical significance of CD81 expression by clonal plasma cells in high-risk smoldering and symptomatic multiple myeloma patients. Leukemia . 2012
  • 2Aref S,Azmy E,EI-Gilany AH.Upregulation of CD200 is associated with regulatory T cell expansion and disease progression in multiple myeloma. Hematological Oncology . 2015
  • 3P Moreau,L Voillat,L Benboukher,C Mathiot,C Dumontet,N Robillard,O Hérault,F Garnache,R Garand,N Varoqueaux,H Avet-Loiseau,J L Harousseau,R Bataille.Rituximab in CD20 positive multiple myeloma. Leukemia . 2007
  • 4N Robillard,S Wuillème,L Lodé,F Magrangeas,S Minvielle,H Avet-Loiseau.CD33 is expressed on plasma cells of a significant number of myeloma patients, and may represent a therapeutic target. Leukemia . 2005
  • 5Moreau Philippe,Robillard Nelly,Avet-Loiseau Herve,Pineau Danielle,Morineau Nadine,Milpied Noel,Harousseau Jean-Luc,Bataille Regis.Patients with CD45 negative multiple myeloma receiving high-dose therapy have a shorter survival than those with CD45 positive multiple myeloma. Haematologica . 2004
  • 6G. Carulli,V. Ottaviano,E. Cannizzo.Multiparameter immunophenotyping by flow cytometry as a diagnostic tool in multiple myeloma and monoclonal gammopathy of undetermined significance. CLINICA TERAPEUTICA . 2012
  • 7Rawstron Andy C,Orfao Alberto,Beksac Meral,Bezdickova Ludmila,Brooimans Rik A,Bumbea Horia,Dalva Klara,Fuhler Gwenny,Gratama Jan,Hose Dirk,Kovarova Lucie,Lioznov Michael,Mateo Gema,Morilla Ricardo,Mylin Anne K,Omedé Paola,Pellat-Deceunync.Report of the European Myeloma Network on multiparametric flow cytometry in multiple myeloma and related disorders. Haematologica . 2008
  • 8Vela-Ojeda J,Garcia-Ruiz Esparza MA,Padilla-Gonzalez Y,et al.CD200 protein,bad prognostic in patients with multiple myeloma. Rev Med Inst Mex Sequro Soc . 2015
  • 9Muccio VE,Saraci E,Gilestro M,et al.Multiple myeloma:new surface antigens for the characterization of plasma cells in the era of novel agents. Cytometry B Clin Cytom . 2015
  • 10Tali Tohami,Liat Drucker,Hava Shapiro,Judith Radnay,Michael Lishn.Overexpression of tetraspanins affects multiple myeloma cell survival and invasive potential. The FASEB Journal . 2007

共引文献1

同被引文献36

引证文献5

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部